Defining Objective Markers of Compliance for Dietary Therapies in IBS

Abroad (travel likely)Recruiting

Conditions

Irritable Bowel Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Prashant Singh, MBBS) · singhpr@med.umich.edu · 734-647-9252
Contact: Principal Investigator (Prashant Singh, MBBS)
Allen Lee, MD, MS (Sub-investigator)

Study leads

Prashant Singh, MBBS
Principal Investigator
University of Michigan

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

Irritable Bowel Syndrome · Constipation

Abroad (travel likely)RecruitingPHASE2

Mesa, United States · Anaheim, United States

Well-being in IBS: Strengths and Happiness (WISH) 2.0

Irritable Bowel Syndrome

Abroad (travel likely)Recruiting

Boston, United States

Probiotics and Biomarkers in Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS)

Abroad (travel likely)Recruiting

Gothenburg, Sweden

Psyllium in Pediatric IBS

Irritable Bowel Syndrome

Abroad (travel likely)RecruitingPHASE2

Durham, United States